Discovery of novel tetracyclic compounds as anaplastic lymphoma kinase inhibitors

被引:32
作者
Kinoshita, Kazutomo [1 ]
Ono, Yoshiyuki [2 ]
Emura, Takashi [2 ]
Asoh, Kohsuke [1 ]
Furuichi, Noriyuki [1 ]
Ito, Toshiya [1 ]
Kawada, Hatsuo [1 ]
Tanaka, Shota [2 ]
Morikami, Kenji [2 ]
Tsukaguchi, Toshiyuki [1 ]
Sakamoto, Hiroshi [1 ]
Tsukuda, Takuo [1 ]
Oikawa, Nobuhiro [1 ]
机构
[1] Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Kanagawa 2478530, Japan
[2] Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Shizuoka 4128513, Japan
关键词
Anaplastic lymphoma kinase; Kinase inhibitors; Antitumor efficacy; LUNG-CANCER; GENE; ALK; IDENTIFICATION; NEUROBLASTOMA; FUSION;
D O I
10.1016/j.bmcl.2011.04.020
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Anaplastic lymphoma kinase (ALK) receptor tyrosine kinase is considered a promising therapeutic target for human cancers. We identified novel tetracyclic derivatives as potent ALK inhibitors. Among them, compound 27 showed strong cytotoxicity against KARPAS-299 with an IC(50) value of 21 nM and significant antitumor efficacy in ALK fusion-positive blood and solid cancer xenograft models in mice without body weight loss. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3788 / 3793
页数:6
相关论文
共 15 条
  • [1] Crystal Structures of Anaplastic Lymphoma Kinase in Complex with ATP Competitive Inhibitors
    Bossi, Roberto T.
    Saccardo, M. Beatrice
    Ardini, Elena
    Menichincheri, Maria
    Rusconi, Luisa
    Magnaghi, Paola
    Orsini, Paolo
    Avanzi, Nilla
    Borgia, Andrea Lombardi
    Nesi, Marcella
    Bandiera, Tiziano
    Fogliatto, Gianpaolo
    Bertrand, Jay A.
    [J]. BIOCHEMISTRY, 2010, 49 (32) : 6813 - 6825
  • [2] Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
    Fleming, Fraser F.
    Yao, Lihua
    Ravikumar, P. C.
    Funk, Lee
    Shook, Brian C.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (22) : 7902 - 7917
  • [3] ALKYLATION OF PHENOL WITH A HOMOALLYLIC HALIDE
    HART, H
    WAGNER, CR
    WU, CY
    CORBIN, JL
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1963, 85 (20) : 3269 - &
  • [4] Synthesis and structure-activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase
    Milkiewicz, Karen L.
    Weinberg, Linda R.
    Albom, Mark S.
    Angeles, Thelma S.
    Cheng, Mangeng
    Ghose, Arup K.
    Roemmele, Renee C.
    Theroff, Jay P.
    Underiner, Ted L.
    Zificsak, Craig A.
    Dorsey, Bruce D.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (12) : 4351 - 4362
  • [5] FUSION OF A KINASE GENE, ALK, TO A NUCLEOLAR PROTEIN GENE, NPM, IN NON-HODGKINS-LYMPHOMA
    MORRIS, SW
    KIRSTEIN, MN
    VALENTINE, MB
    DITTMER, KG
    SHAPIRO, DN
    SALTMAN, DL
    LOOK, AT
    [J]. SCIENCE, 1994, 263 (5151) : 1281 - 1284
  • [6] Identification of ALK as a major familial neuroblastoma predisposition gene
    Mosse, Yael P.
    Laudenslager, Marci
    Longo, Luca
    Cole, Kristina A.
    Wood, Andrew
    Attiyeh, Edward F.
    Laquaglia, Michael J.
    Sennett, Rachel
    Lynch, Jill E.
    Perri, Patrizia
    Laureys, Genevieve
    Speleman, Frank
    Kim, Cecilia
    Hou, Cuiping
    Hakonarson, Hakon
    Torkamani, Ali
    Schork, Nicholas J.
    Brodeur, Garrett M.
    Tonini, Gian P.
    Rappaport, Eric
    Devoto, Marcella
    Maris, John M.
    [J]. NATURE, 2008, 455 (7215) : 930 - U22
  • [7] Biological role of anaplastic lymphoma kinase in neuroblastoma
    Osajima-Hakomori, Y
    Miyake, I
    Ohira, M
    Nakagawara, A
    Nakagawa, A
    Sakai, R
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (01) : 213 - 222
  • [8] Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity
    Ott, Gregory R.
    Tripathy, Rabindranath
    Cheng, Mangeng
    McHugh, Robert
    Anzalone, Andrew V.
    Underiner, Ted L.
    Curry, Matthew A.
    Quail, Matthew R.
    Lu, Lihui
    Wan, Weihua
    Angeles, Thelma S.
    Albom, Mark S.
    Aimone, Lisa D.
    Ator, Mark A.
    Ruggeri, Bruce A.
    Dorsey, Bruce D.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (09): : 493 - 498
  • [9] Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1
    Pulford, K
    Lamant, L
    Morris, SW
    Butler, LH
    Wood, KM
    Stroud, D
    Delsol, G
    Mason, DY
    [J]. BLOOD, 1997, 89 (04) : 1394 - 1404
  • [10] GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers
    Sabbatini, Peter
    Korenchuk, Susan
    Rowand, Jason L.
    Groy, Arthur
    Liu, Qi
    Leperi, Dominic
    Atkins, Charity
    Dumble, Melissa
    Yang, Jingsong
    Anderson, Kelly
    Kruger, Ryan G.
    Gontarek, Richard R.
    Maksimchuk, Kenneth R.
    Suravajjala, Sapna
    Lapierre, Russell R.
    Shotwell, J. Brad
    Wilson, Joseph W.
    Chamberlain, Stanley D.
    Rabindran, Sridhar K.
    Kumar, Rakesh
    [J]. MOLECULAR CANCER THERAPEUTICS, 2009, 8 (10) : 2811 - 2820